Can Oracle Get Close to a $1 Trillion Market Cap Again?

Oracle’s cloud revenue grew 47% YoY in fiscal 2026 Q4, with total revenue up 21%, supporting a bullish view despite stock weakness (>50% from the prior peak). The main overhang is $638B in remaining performance obligations, of which $300B+ is tied to an OpenAI contract with delivery timing uncertainty (data centers stated for 2027) and affordability concerns (OpenAI posted a $38.5B net loss in 2025 vs a $60B/year commitment). Valuation has reset to a 26x P/E (down from the 50s previously) and a PEG of 0.86, implying a margin of safety if AI/cloud tailwinds continue.

Analysis

The market is still treating Oracle’s backlog as if it were broadly de-risked revenue, but the important distinction is counterparty quality. When a single private customer drives that much of future billings, the stock stops trading like a classic software compounder and starts trading like a long-dated project-finance story with equity upside but financing-dependent timing. That is a different risk profile, and it justifies a discount until the customer’s funding path is independently verifiable.

Near term, the stock will react more to narrative updates than fundamentals: any hint of delay, scope change, or external financing stress can hit the multiple first and the numbers later. Over the next 1-3 months, the key catalyst is whether management can show diversified backlog conversion and cleaner delivery milestones; over 6-18 months, the question is whether Oracle’s cloud growth is durable enough to absorb one customer’s noise without a permanent de-rating. If the AI buildout remains intact, NVDA is the cleaner second-order beneficiary because capex intensity can continue even if Oracle’s equity story remains volatile.

Contrarian view: the selloff may already price in some bad news, but not enough if the market continues to discover that a large portion of the backlog is effectively optional until financing is secured. The right framework is not P/E alone; it is backlog-adjusted quality, cancellation risk, and cash conversion timing. If OpenAI funding improves or Oracle proves multiple quarters of diversified backlog growth, the bearish case weakens quickly; absent that, this is more likely a valuation trap than a clean rebound.

Key Decisions for Investors

• Pair trade: long NVDA / short ORCL into strength over the next 1-3 months. Thesis: AI capex can remain robust while Oracle-specific backlog quality stays discounted; best risk/reward if Oracle re-rates on narrative but not on independently confirmed contract economics.
• Use ORCL rallies to buy 1-3 month put spreads rather than outright shorting. This caps theta bleed while targeting a re-pricing if there is any headline around OpenAI funding, delivery timing, or backlog concentration.
• If you want upside exposure, wait for evidence of diversified backlog conversion before adding ORCL. The cleanest long entry is a quarter where management demonstrates that non-OpenAI cloud demand is still compounding and cash conversion is not being pulled forward by capex-heavy commitments.
• Set a watch item on OpenAI financing milestones and Oracle delivery commentary. A credible external funding package would be the main falsifier for the short-ORCL / long-NVDA relative-value view.